MARGIOTTA, NICOLA

MARGIOTTA, NICOLA  

DIPARTIMENTO DI CHIMICA  

Mostra records
Risultati 1 - 20 di 179 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
9[(aminoalkyl)amino]nitroacridines: kinetic vs thermodynamic interactions towards platinum(II) and factors ruling their tautomeric equilibrium. 1-gen-1999 Maresca, L; Cerasino, L; Margiotta, Nicola; Natile, G.
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 1-gen-2013 Piccinonna, S; Margiotta, Nicola; Denora, Nunzio; Iacobazzi, Rm; Pacifico, Concetta; Trapani, Giuseppe; Natile, Giovanni
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues 1-gen-2008 Margiotta, Nicola; Capitelli, F.; Ostuni, R.; Natile, Giovanni
A novel Platinum(II) complex tethered to a ligand having high affinity for the Peripheral Benzodiazepine Receptor 1-gen-2007 Margiotta, Nicola; Ostuni, R; Ranaldo, R; Denora, Nunzio; Laquintana, Valentino; Trapani, G; Natile, G.
Activation of antitumoral platinum prodrugs for the local treatment of bone tumors by inclusion in bioactive inorganic matrices. 1-gen-2009 Margiotta, Nicola; Ostuni, R; Piccinonna, S; Natile, G.
Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine 1-gen-2002 Margiotta, Nicola; Fanizzi, F. P.; Cini, R.; Tamasi, G.; Natile, Giovanni
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA 1-gen-2017 Kasparkova, Jana; Kostrhunova, Hana; Novohradsky, Vojtech; Pracharova, Jitka; Curci, Alessandra; Margiotta, Nicola; Natile, Giovanni; Brabec, Viktor
Antitumor drugs delivery by bone substitute biomimetic hydroxyapatite nanocrystals. 1-gen-2006 Margiotta, Nicola; Palazzo, B; Iafisco, M; Laforgia, M; Natile, G; Bianchi, C; Walsh, D; Roveri, N.
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 1-gen-2000 Andersen, B; Margiotta, Nicola; Intini, Fp; Sivo, Mf; Coluccia, Mauro; Natile, G; Sletten, E.
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 1-gen-2000 Andersen, B.; Margiotta, Nicola; Coluccia, Mauro; Natile, Giovanni; Sletten, E.
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 1-gen-2004 Margiotta, Nicola; Bergamo, A; Sava, G; Padovano, G; DE CLERCQ, E; Natile, Giovanni
Assessing inter-nucleot(s)ide interactions by conformational studies of adducts between platinum complexes with carrier ligand unable to form H-bonds and guanine derivatives. 1-gen-2003 Margiotta, Nicola; Papadia, P; Fanizzi, Fp; Natile, G.
Back to the future with Kiteplatin: an efficacious drug against oxaliplatin-refractory colorectal cancer. 1-gen-2012 Margiotta, Nicola; Petruzzella, E; Natile, G.
Bioactive Inorganic Matrices for the Local Delivery of Platinum-based Prodrugs in the Treatment of Bone Tumors 1-gen-2011 Margiotta, Nicola; Piccinonna, S; Iafisco, M; Roveri, N; Natile, G.
Biomimetic hydroxyapatite/drug nanocrystals as potential bone substitutes with anti-tumour drug delivery properties 1-gen-2007 Palazzo, B; Iafisco, M; Laforgia, M; Margiotta, Nicola; Natile, Giovanni; BIANCHI C., L; Walsh, D; Mann, S; Roveri, N.
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds 1-gen-2007 Margiotta, Nicola; Ostuni, R; Teoli, D; Morpurgo, M; Realdon, N; Palazzo, B; Natile, Giovanni
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds. 1-gen-2007 Margiotta, Nicola; Ostuni, R; Teoli, D; Morpurgo, M; Natile, G.
Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer 1-gen-2017 Nadar, Robin A.; Margiotta, Nicola; Iafisco, Michele; van den Beucken, Jeroen J. J. P.; Boerman, Otto C.; Leeuwenburgh, Sander C. G.
Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer 1-gen-2017 Nadar, Robin A.; Margiotta, Nicola; Iafisco, Michele; van den Beucken, Jeroen J. J. P.; Boerman, Otto C.; Leeuwenburgh, Sander C. G.
Bone tumor–targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells 1-gen-2021 Nadar, R. A.; Franssen, G. M.; Van Dijk, N. W. M.; Codee-van der Schilden, K.; de Weijert, M.; Oosterwijk, E.; Iafisco, M.; Margiotta, N.; Heskamp, S.; van den Beucken, J. J. J. P.; Leeuwenburgh, S. C. G.